Tartary Buckwheat Flavonoids Relieve Non-alcoholic Fatty Liver Disease by Inhibiting Lipid Accumulation, Inflammation, and Regulating Intestinal Flora

被引:3
作者
Xu, Ping [1 ]
Liu, Juxiong [1 ]
Li, Zhe [1 ]
Kan, Xingchi [1 ]
Hu, Guiqiu [1 ]
Cao, Yu [1 ]
Guo, Wenjin [1 ]
Fu, Shoupeng [1 ]
机构
[1] Jilin Univ, Coll Vet Med, Changchun, Jilin, Peoples R China
来源
REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY | 2023年 / 33卷 / 05期
关键词
Intestinal flora; Liver inflammation; Lipid metabolism; Obesity reduction; Quercetin; Rutin; NF-KAPPA-B; HEPATIC STEATOSIS; WESTERN DIET; PPAR-ALPHA; ACTIVATION; NAFLD; FIBROSIS; GAERTN; INJURY; CELLS;
D O I
10.1007/s43450-023-00406-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Non-alcoholic fatty liver disease is characterized by liver damage and steatosis, which is often accompanied by inflammation. Tartary buckwheat flavone has been shown to have a range of anti-inflammatory effects, but its mechanism of action on non-alcoholic fatty liver disease remains unclear. In this study, a non-alcoholic fatty liver disease model induced by high-fat diet in vivo and HepG2 cells stimulated by palmitic acid in vitro were constructed, and the effect of tartary buckwheat flavone on high-fat diet-induced non-alcoholic fatty liver disease and its potential mechanism was explored by H&E staining, PCR, Western blot, and 16S rRNA high-throughput sequencing. The results showed that compared with the high-fat diet group, tartary buckwheat flavone significantly reduced liver and body weight and alleviated pathological damage of liver tissue in mice, and the biochemical indexes of total cholesterol, triacylglyceride, alanine aminotransferase, and aspartate aminotransferase were significantly decreased. Further studies showed that tartary buckwheat flavone significantly reduced the protein levels of inflammatory mediators myeloperoxidase, iNOS, COX2, IL-6, IL-1 beta, and TNF-alpha. In vitro studies also showed that tartary buckwheat flavone significantly improved palmitic acid-induced HepG2 cell lipid accumulation and increased inflammatory factors. Mechanism studies showed that tartary buckwheat flavone alleviated the disorder of lipid metabolism by activating AMPK, decreasing sterol regulatory element-binding protein-1 (SREBP1) and acetyl-COA carboxylase protein levels. Tartary buckwheat flavone significantly inhibited high-fat diet-induced MAPK and NF-kappa B signaling pathways to reduce the release of pro-inflammatory mediators, and then alleviate the inflammatory response. In addition, tartary buckwheat flavone significantly alleviated the intestinal flora disorder induced by high-fat diet through increasing the relative abundance of beneficial bacteria Dubosiella and Bacteroidetes. Our study found that tartary buckwheat flavone alleviates non-alcoholic fatty liver disease by mitigating the disorder of lipid metabolism and inflammatory response and regulating the composition of intestinal flora.
引用
收藏
页码:965 / 979
页数:15
相关论文
共 51 条
  • [1] Diosmin Alleviates Doxorubicin-Induced Liver Injury via Modulation of Oxidative Stress-Mediated Hepatic Inflammation and Apoptosis via NfkB and MAPK Pathway: A Preclinical Study
    AlAsmari, Abdullah F.
    Alharbi, Metab
    Alqahtani, Faleh
    Alasmari, Fawaz
    AlSwayyed, Mohammed
    Alzarea, Sami I.
    Al-Alallah, Ibrahim A.
    Alghamdi, Adel
    Hakami, Hassan M.
    Alyousef, Meshal K.
    Sari, Youssef
    Ali, Nemat
    [J]. ANTIOXIDANTS, 2021, 10 (12)
  • [2] Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
    Aron-Wisnewsky, Judith
    Vigliotti, Chloe
    Witjes, Julia
    Le, Phuong
    Holleboom, Adriaan G.
    Verheij, Joanne
    Nieuwdorp, Max
    Clement, Karine
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (05) : 279 - 297
  • [3] Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes
    Baldus, S
    Heeschen, C
    Meinertz, T
    Zeiher, AM
    Eiserich, JP
    Münzel, T
    Simoons, ML
    Hamm, CW
    [J]. CIRCULATION, 2003, 108 (12) : 1440 - 1445
  • [4] Böhm T, 2013, J HEPATOL, V59, P563, DOI 10.1016/j.jhep.2013.04.025
  • [5] The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota
    Boursier, Jerome
    Mueller, Olaf
    Barret, Matthieu
    Machado, Mariana
    Fizanne, Lionel
    Araujo-Perez, Felix
    Guy, Cynthia D.
    Seed, Patrick C.
    Rawls, John F.
    David, Lawrence A.
    Hunault, Gilles
    Oberti, Frederic
    Cales, Paul
    Diehl, Anna Mae
    [J]. HEPATOLOGY, 2016, 63 (03) : 764 - 775
  • [6] A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonation
    Bututoglu, Beyza
    Rey-Bedon, Camito
    Kang, Young Bok
    Mert, Safak
    Yarmush, Martin L.
    Usta, Berk
    [J]. LAB ON A CHIP, 2019, 19 (18) : 3022 - 3031
  • [7] Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
    Cani, Patrice D.
    Bibiloni, Rodrigo
    Knauf, Claude
    Neyrinck, Audrey M.
    Neyrinck, Audrey M.
    Delzenne, Nathalle M.
    Burcelin, Remy
    [J]. DIABETES, 2008, 57 (06) : 1470 - 1481
  • [8] AMPK signalling in health and disease
    Carling, David
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2017, 45 : 31 - 37
  • [9] Deng Yuanjun, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5030106
  • [10] Genetics and epigenetics of NAFLD and NASH: Clinical impact
    Eslam, Mohammed
    Valenti, Luca
    Romeo, Stefano
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 (02) : 268 - 279